Cargando…
The Potential of Transforming Growth Factor-beta Inhibitor and Vascular Endothelial Growth Factor Inhibitor as Therapeutic Agents for Uterine Leiomyoma
Background: Uterine leiomyoma is the most common benign tumor in women of reproductive age, and it can cause infertility. The growth of uterine leiomyoma is mediated by various steroids and growth factors. The purpose of this study was to evaluate the expression of various growth factors in uterine...
Autores principales: | Park, Jung Yoon, Chae, Boah, Kim, Mee-Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608041/ https://www.ncbi.nlm.nih.gov/pubmed/36313223 http://dx.doi.org/10.7150/ijms.75203 |
Ejemplares similares
-
Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
por: Moon, Jeong Min, et al.
Publicado: (2018) -
Cardiotoxicity with vascular endothelial growth factor inhibitor therapy
por: Touyz, Rhian M., et al.
Publicado: (2018) -
Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients
por: Lee, Minkyoung, et al.
Publicado: (2018) -
Vascular Endothelial Growth Factors and Their Inhibitors in Ocular Neovascular Disorders
por: Homayouni, Mansour
Publicado: (2009) -
Cardiovascular Toxicity Induced by Vascular Endothelial Growth Factor Inhibitors
por: Mihalcea, Diana, et al.
Publicado: (2023)